Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
APTA Offers Group, Individual Health Insurance That Could Help You Save

Feb 6, 2023/News

The APTA Health Benefits Marketplace leverages the association's membership size to keep costs down.

Your MIPS Status May Have Changed: Here's How to Find Out

Nov 30, 2022/News

CMS has updated eligibility determinations based on the most recent reporting periods. Make sure you know where you stand.

Elements of Documentation Within the Patient-Client Management Model

Jun 28, 2024/Article

The main documentation elements are: initial examination and evaluation, visit, reexamination, and conclusion of episode of care summary.

Policy Progress and Patient-First Thinking: Takeaways from the 2026 Maley Panel

Mar 23, 2026/Article

APTA Board member Kelley Kubota, PT, DPT, MS, moderated the John H.P. Maley Clinical Impact Lectureship Award panel featuring William Boissonnault, PT, DPT, DHSc, FAPTA, Andrea Behrman, PT, PhD, FAPTA, and Nicole Stout, PT, DPT, FAPTA. For the 31st annual John H.P. Maley Clinical Impact Lectureship Award,

Sport Concussion Assessment Tool 3 (SCAT3) and Child-SCAT3

Aug 9, 2018/Test & Measure

Used to assess concussions in athletes who are aged 13 years or older.

APTA in 2020, Part 5: More Highlights From a Difficult Year

From increased member engagement to advocacy wins, reasons to celebrate.

Defining Moment | From Nonclinical to Clinical and Back Again

Oct 1, 2025/Column

One PT reflects on a career shaped by unexpected turns, personal discovery, and the enduring impact of patient care.

Student Focus

Jun 1, 2024/Column

Corbin Olson, SPT, a second-year student at the University of Mary, interviews Michael Murray, PT, DPT, president of the APTA Aquatics.

Defining Moment: On a Mission to Promote Pelvic Health

Sep 1, 2024/Column

This pelvic health PT is on a mission to make pelvic health care a reality for all.

APTA Coronavirus Update: May 5

May 5, 2021/Roundup

PASC, post-COVID-19 neuropathy, herd immunity, and more.